• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Andrea Applegate

Andrea Applegate

Articles

ARTICLES

BioWorld MedTech’s Neurology Extra for Nov. 20, 2020

Nov. 20, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Wireless chip developed to improve brain research; Diabetes increases damage around amyloid plaques in Alzheimer’s; Smartphone keystrokes show promise in monitoring progression of MS.
Read More

BioWorld MedTech’s Neurology Extra for Nov. 13, 2020

Nov. 13, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Individualized brain stimulation therapy improves aphasia in stroke survivors; Weekly physical activity may help prevent Alzheimer’s in people with mild cognitive impairment; Diagnosing Parkinson’s via mitochondria interaction networks.
Read More

BioWorld MedTech’s Neurology Extra for Nov. 6, 2020

Nov. 6, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: AI helps detect brain aneurysms on CT angiography; BBB studies advancing focused ultrasound treatment for Parkinson’s; Study reveals unexpected protective role for brain swelling after injury.
Read More

BioWorld MedTech’s Neurology Extra for Oct. 30, 2020

Oct. 30, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Software developed to objectively calculate white matter hyperintensities; CSF biomarkers point to underlying cause of neural damage in COVID-19; Scientists discover how cryptochrome mutation leads to sleep disorder; Physical labor significantly increases the risk of dementia.
Read More

BioWorld MedTech’s Neurology Extra for Oct. 23, 2020

Oct. 23, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: MIT develops wearable sensor for ALS patients; Cord blood DNA can hold clues for early ASD diagnosis and intervention; ENIGMA consortium offers hope for improving treatment of brain injuries.
Read More

BioWorld MedTech’s Neurology Extra for Oct. 16, 2020

Oct. 16, 2020
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Study highlights links between inflammation and Parkinson’s disease; Some sedentariness in older adults OK when it comes to brain, cognition; Microbiome metabolite affects neuropathic pain; Following neonatal lead enables spinal cord repair in mice.
Read More

BioWorld MedTech’s Neurology Extra for Oct. 9, 2020

Oct. 9, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Hydrogel developed to help repair damaged nerves; Evidence of Alzheimer’s, Parkinson’s & MND in brains of young people exposed to dirty air; Study identifies brain cells most affected by epilepsy and new targets for their treatment.
Read More

BioWorld MedTech’s Neurology Extra for Sept. 25, 2020

Sep. 25, 2020
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Putting virtual rehab for stroke patients to the test; Deep learning tool advances study of neural degeneration; Popular opinion correct on fear, anxiety.
Read More

BioWorld MedTech’s Neurology Extra for Sept. 18, 2020

Sep. 18, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: New smart drug delivery system may help treatment for neurological disorders; Imaging probe developed for Alzheimer's disease; Potential target identified for migraine therapy.
Read More

BioWorld MedTech’s Neurology Extra for Sept. 11, 2020

Sep. 11, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: New molecule restores lost connections in the spinal cord, brain of mice; Brain stimulation reduces dyslexia deficits; Nerivio wearable piloted for relief in patients with chronic migraine.
Read More
View All Articles by Andrea Applegate

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 20, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 18, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 17, 2025
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe